Page 326 - SAMRC Annual Report 2024-2025

ANNUAL FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025
NOTES TO THE ANNUAL FINANCIAL STATEMENTS

(CONTINUED)

2025 2024
31 MARCH 31 MARCH
R R
34. Cash generated from (used in) operations

Surplus (deficit) 60,666,208 (21,366,607)
Adjustments for:
Depreciation and amortisation 37,225,735 32,649,514
Loss on sale of assets and liabilities 2,616,517 3,621,990
Gain on foreign exchange (122,888) (1,162,965)
Fair value adjustments (1,477,299) (211,431)
Impairment deficit 1,353,329 1,235,223
Debt impairment 3,166,724 (136,828)
Movements in retirement benefit assets and liabilities (2,457,000) (2,081,000)
Movements in provisions 35,746,396 9,945,331
Capitalisation of financial assets (208,760) (191,740)
Non-cash adjustment on biological assets 5,000 –
Non-cash adjustment on living resources (280,959) (146,531)
Other non-cash items: Donation in kind – (20,622,547)
Other non-cash items: asset replacement – (2,010,452)
Other non-cash items: property, plant and equipment 16,150 3,634,725
Changes in working capital:
Receivables from exchange transactions 10,739,057 27,653,989
Receivables from non-exchange transactions (12,668,148) (3,538,369)
Prepayments (1,696,054) (4,351,391)
Payables from exchange transactions (12,089,501) (55,028,604)
VAT 12,191,457 (9,231,214)
Deferred income 90,118,853 (100,995,378)

222,844,817 (142,334,285)

324 SAMRC ANNUAL REPOR T 2025-26